revlimid
Showing 1 - 20 of 20
Chronic Lymphocytic Leukemia(CLL), Small Lymphocytic Lymphoma Trial in Hackensack (Revlimid, Azacitidine)
Terminated
- Chronic Lymphocytic Leukemia(CLL)
- Small Lymphocytic Lymphoma
- Revlimid
- Azacitidine
-
Hackensack, New JerseyHackensack University Medical Center
Jun 24, 2022
Lymphoma, Non-Hodgkin Lymphoma, DLBCL Trial run by the NCI (obinutuzumab, prednisone, Revlimid)
Recruiting
- Lymphoma
- +3 more
- obinutuzumab
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 6, 2022
Chronic Lymphocytic Leukemia, CLL Trial in La Jolla (Revlimid, Rituximab)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- CLL
- Revlimid
- Rituximab
-
La Jolla, CaliforniaUniversity of California, San Diego
Sep 2, 2021
Multiple Myeloma Trial in Taipei (Revlimid)
Completed
- Multiple Myeloma
- Revlimid
-
Taipei, TaiwanNTUH
Nov 14, 2019
Prostate Cancer Trial in Baltimore (Revlimid)
Completed
- Prostate Cancer
- Revlimid
-
Baltimore, MarylandThe Harry and Jeanette Weinberg Building
Apr 11, 2019
Follicular Lymphoma Trial in Shanghai (Revlimid)
Unknown status
- Follicular Lymphoma
- Revlimid
-
Shanghai, Shanghai, ChinaRuijin Hospital
Jul 4, 2019
Multiple Myeloma Trial in United States (Revlimid, Velcade, dexamethasone)
Terminated
- Multiple Myeloma
- Revlimid
- +3 more
-
Los Angeles, California
- +4 more
Jun 26, 2018
Multiple Myeloma Trial in Durham (Velcade, Cyclophosphamide, Revlimid)
Terminated
- Multiple Myeloma
- Velcade
- +2 more
-
Durham, North CarolinaDuke University Medical Center
Apr 26, 2017
Melanoma Trial run by the NCI (Revlimid)
Completed
- Melanoma
- Revlimid
-
Bethesda, MarylandNational Cancer Institute (NCI)
Nov 14, 2016
Waldenstrom Macroglobulinemia Trial in France (Revlimid)
Completed
- Waldenstrom Macroglobulinemia
- Revlimid
-
Bayonne, France
- +6 more
Jun 6, 2017
Multiple Myeloma Trial in Spain (Melphalan, Prednisone, Velcade)
Completed
- Multiple Myeloma
- Melphalan
- +4 more
-
Palma de Mallorca, Baleares, Spain
- +62 more
Jan 16, 2017
Multiple Myeloma Trial in Stockholm (Revlimid)
Completed
- Multiple Myeloma
- Revlimid
-
Stockholm, Sweden
- +1 more
Mar 24, 2016
Multiple Myeloma Trial in Little Rock (Revlimid)
Completed
- Multiple Myeloma
- Revlimid
-
Little Rock, ArkansasUniversity of Arkansas for Medical Science-MIRT
Sep 29, 2015
Acute Myeloid Leukemia Trial in Toronto (Revlimid)
Completed
- Acute Myeloid Leukemia
- Revlimid
-
Toronto, Ontario, CanadaUniversity Health Network, Princess Margaret Hospital
Jun 17, 2015
Pancreatic Carcinoma Metastatic, Pancreatic Ductal Adenocarcinoma Trial in Stockholm (Gemzar, Revlimid)
Completed
- Pancreatic Carcinoma.
- Gemzar
- Revlimid
-
Stockholm, Solna, SwedenKarolinska University Hospital
Nov 26, 2014
Chronic Myelomonocytic Leukemia Trial in Austria (Revlimid)
Unknown status
- Chronic Myelomonocytic Leukemia
- Revlimid
-
Linz, Oberösterreich, Austria
- +9 more
Mar 6, 2015
Diffuse Large B-cell Lymphoma. Trial in Hackensack, Durham (Revlimid)
Unknown status
- Diffuse Large B-cell Lymphoma.
- Revlimid
-
Hackensack, New Jersey
- +1 more
Feb 2, 2014
Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Houston (Revlimid)
Completed
- Acute Myelogenous Leukemia
- Myelodysplastic Syndrome
- Revlimid
-
Houston, TexasUT MD Anderson Cancer Center
Aug 5, 2013
Relapse, Refractory Multiple Myeloma Trial in Wuerzburg (Revlimid)
Completed
- Relapse
- Refractory Multiple Myeloma
- Revlimid
-
Wuerzburg, Bavaria, GermanyDept. of Internal Medicine II, University of Wuerzburg
Aug 3, 2009